    
The links after "Participants" show which Southwest Oncology Group institutions are eligible to participate in this study.
The orange "Where is This Study Open?" tab at the bottom of the page shows the institutions whose Institutional Review Boards (IRBs) have approved the protocol so that it can be opened at that institution. Clicking on the Institution Name will show the points of contact for information about this study at that institution.
|
|
S0000A
- Phase III(Closed)
|
| PREADVISE, Prevention of Alzheimer's Disease with Vitamin E and Selenium, Phase III Ancillary to S0000 - SELECT |
|
Treatment: Vitamin E, Selenium
Disease Committee: Other
|
|
Study Coordinator(s): William Markesbery, M.D. Participants: Institutions listed in protocol Appendix 19.5 Eligibility Criteria: Only SELECT participants may be considered for this study
|
Activation Date: 5/17/2002
Closure Date: 9/30/2009
|
